Evidence map›Paper›PMID 26936494›Full record

ArticleJournal of feline medicine and surgery2016

ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease.

Andrew H Sparkes, Sarah Caney, Serge Chalhoub, Jonathan Elliott, Natalie Finch, Isuru Gajanayake, Catherine Langston, Hervé P Lefebvre, Joanna White, Jessica Quimby

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of feline medicine and surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrew H SparkesInternational Cat Care/ISFM, UK andy@icatcare.org.
Sarah CaneyVet Professionals, UK.
Serge ChalhoubFaculty of Veterinary Medicine, University of Calgary, Canada.
Jonathan ElliottDepartment of Comparative Biomedical Sciences, Royal Veterinary College, UK.
Natalie FinchBristol Renal, School of Clinical Sciences, University of Bristol, UK.
Isuru GajanayakeWillows Referral Service, Solihull, UK.
Catherine LangstonDepartment of Veterinary Clinical Sciences, Ohio State University, USA.
Hervé P LefebvreClinical Research Unit, National Veterinary School of Toulouse (ENVT), France.
Joanna WhiteSmall Animal Specialist Hospital, Sydney, Australia.
Jessica QuimbyDepartment of Clinical Veterinary Sciences, Colorado State University, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

practical relevanceChronic kidney disease (CKD) is one of the most commonly diagnosed diseases in older cats. In most cats, CKD is also a progressive disease and can be accompanied by a wide range of clinical and clinicopathological changes. These ISFM Consensus Guidelines have been developed by an independent panel of clinicians and academics to provide practical advice on the diagnosis and management of this complex disease. CLINICAL CHALLENGES: Although CKD is a common clinical problem in cats, the manifestations of disease vary between individuals. Thus there is a need for careful and repeat evaluation of cats with CKD and adjustment of therapy according to individual needs. In addition to addressing problems arising from CKD and improving quality of life (QoL) for the patient, therapy may also target slowing the underlying progression of disease and hence prolonging life. While maintaining QoL is of paramount importance in our patients, this can be challenging when multiple therapies are indicated. In some cases it is necessary to prioritise therapy, given an understanding of what is likely to most benefit the individual patient. EVIDENCE BASE: In preparing these Guidelines, the Panel has carefully reviewed the existing published literature, and has also graded the quality of evidence for different interventions to help to provide practical recommendations on the therapeutic options for feline CKD. This is a field of veterinary medicine that has benefited from some excellent published clinical research and further research findings will undoubtedly modify the recommendations contained in these Guidelines in the future.

Indexed as

Practice Guidelines as TopicAnimalsCat DiseasesCatsConsensusDisease ManagementDisease ProgressionRenal Insufficiency, ChronicSocieties, Medical

Identifiers

PMID26936494
PMCPMC11148907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.